We are live on ! Find out more
IMPV

Imperva, Inc.
IMPV

Delisted

IMPV was delisted on the 9th of January, 2019.

181 hedge funds and large institutions have $1.55B invested in Imperva, Inc. in 2017 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 84 increasing their positions, 48 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

217% more call options, than puts

Call options by funds: $28.6M | Put options by funds: $9M

75% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 48

17% more capital invested

Capital invested by funds: $1.32B → $1.55B (+$225M)

4% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 25

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

1% less funds holding

Funds holding: 182181 (-1)

Holders
181
Holders Change
-1
Holders Change %
-0.55%
% of All Funds
4.51%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.1%
New
26
Increased
84
Reduced
48
Closed
25
Calls
$28.6M
Puts
$9M
Net Calls
+$19.6M
Net Calls Change
+$9.2M
Name Holding Trade Value Shares
Change
Change in
Stake
EC
1
Eminence Capital
New York
$157M -$1.03M -21,995 -0.7%
Vanguard Group
2
Vanguard Group
Pennsylvania
$117M +$4.65M +99,799 +4%
EM
3
Elliott Management
New York
$113M
BlackRock
4
BlackRock
New York
$102M +$10M +215,170 +11%
JP Morgan Chase
5
JP Morgan Chase
New York
$69.5M -$8.14M -174,582 -11%
EAM
6
Eagle Asset Management
Florida
$61.2M +$8.98M +192,625 +18%
CS
7
Credit Suisse
Switzerland
$61.1M +$5.5M +117,832 +10%
ClearBridge Investments
8
ClearBridge Investments
New York
$60.4M +$21.8K +468 +0%
Citadel Advisors
9
Citadel Advisors
Florida
$42.7M +$23.5M +502,927 +129%
EMG
10
ETF Managers Group
New Jersey
$41.9M +$40.8M +875,418 New
Goldman Sachs
11
Goldman Sachs
New York
$34M +$1.63M +34,923 +5%
State Street
12
State Street
Massachusetts
$29M +$3.44M +73,726 +14%
EA
13
Emerald Advisers
Pennsylvania
$27.2M -$3.66M -78,464 -12%
Bank of America
14
Bank of America
North Carolina
$25.5M +$916K +19,634 +4%
NRC
15
North Run Capital
Massachusetts
$24.4M -$11.2M -240,000 -32%
Alyeska Investment Group
16
Alyeska Investment Group
Illinois
$22.9M -$3.51M -75,342 -14%
EMFAT
17
Emerald Mutual Fund Advisers Trust
Pennsylvania
$22.1M -$1.97M -42,212 -8%
CAM
18
Cortina Asset Management
Wisconsin
$22M -$275K -5,894 -1%
Northern Trust
19
Northern Trust
Illinois
$20.9M +$1.9M +40,778 +10%
Citigroup
20
Citigroup
New York
$20.6M +$11.4M +244,574 +131%
Morgan Stanley
21
Morgan Stanley
New York
$19.3M +$8.57M +183,819 +83%
PAMU
22
Pictet Asset Management (UK)
United Kingdom
$17.6M -$5.35M -114,627 -24%
Two Sigma Advisers
23
Two Sigma Advisers
New York
$17.5M +$9.32M +199,800 +120%
Millennium Management
24
Millennium Management
New York
$16.9M -$9.45M -202,536 -36%
Two Sigma Investments
25
Two Sigma Investments
New York
$16.1M +$6.87M +147,191 +78%

IMPV Hedge Fund Activity: Q2 2017 in Review

181 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Imperva, Inc. (IMPV) for Q2 2017, worth a combined $1.55B — up 17% from $1.32B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new IMPV positions and 25 closed out — a net gain of 1 holder — while 84 added to existing stakes and 48 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $23.5M. The largest seller was Penserra Capital Management, exiting entirely with an estimated $36.7M sold.

  • 181 institutional investors held Imperva, Inc. (IMPV) as of Q2 2017, down from 182 in Q1 2017.
  • Funds reported $1.55B of Imperva, Inc. stock for Q2 2017, up 17% quarter-over-quarter.
  • 26 funds opened new Imperva, Inc. positions in Q2 2017 and 25 closed out, a net change of +1 holder.
  • The largest Imperva, Inc. buyer in Q2 2017 was Citadel Advisors, an estimated $23.5M added.
  • The largest Imperva, Inc. seller in Q2 2017 was Penserra Capital Management, an estimated $36.7M sold.

Based on aggregated 13F filings for Q2 2017.